GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
GT Biopharma, Inc.
GT Biopharma, Inc.
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Stanford University
Novartis
Stanford University
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Mayo Clinic